Variant report
Variant | nsv824866 |
---|---|
Chromosome Location | chr9:16563830-16565983 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs943744 | chr9:16563907-16563908 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs549934028 | chr9:16563949-16563950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541147518 | chr9:16563995-16563996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559452408 | chr9:16564000-16564001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530322982 | chr9:16564001-16564002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149990457 | chr9:16564007-16564008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370008104 | chr9:16564010-16564011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376269826 | chr9:16564056-16564057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188357081 | chr9:16564071-16564072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570371015 | chr9:16564095-16564096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs943745 | chr9:16564112-16564113 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs552569825 | chr9:16564125-16564126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73419408 | chr9:16564140-16564141 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs534984665 | chr9:16564164-16564165 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568312665 | chr9:16564168-16564169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568168897 | chr9:16564179-16564180 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536087705 | chr9:16564182-16564183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12683382 | chr9:16564187-16564188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73419411 | chr9:16564214-16564215 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs576316678 | chr9:16564241-16564242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543327392 | chr9:16564254-16564255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs74375224 | chr9:16564264-16564265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192220262 | chr9:16564307-16564308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111679261 | chr9:16564312-16564313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112438772 | chr9:16564360-16564361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374772450 | chr9:16564393-16564394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540981902 | chr9:16564403-16564404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559538539 | chr9:16564408-16564409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529807309 | chr9:16564416-16564417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs374488824 | chr9:16564424-16564425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12338548 | chr9:16564464-16564465 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs185804916 | chr9:16564586-16564587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531107050 | chr9:16564589-16564590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576899931 | chr9:16564681-16564682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs539498238 | chr9:16564704-16564705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571085968 | chr9:16564708-16564709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528469787 | chr9:16564714-16564715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546586298 | chr9:16564743-16564744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568255845 | chr9:16564755-16564756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199610324 | chr9:16564803-16564804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143667264 | chr9:16564804-16564805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190328737 | chr9:16564806-16564807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554368231 | chr9:16564827-16564828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375997464 | chr9:16564836-16564837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569771076 | chr9:16564854-16564855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555786849 | chr9:16564889-16564890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs138103984 | chr9:16564918-16564919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577065849 | chr9:16564919-16564920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149533346 | chr9:16564933-16564934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182155916 | chr9:16564959-16564960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21611746 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:16542600-16564000 | Weak transcription | HUVEC | blood vessel |
2 | chr9:16543800-16567000 | Weak transcription | HSMMtube | muscle |
3 | chr9:16546000-16568400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr9:16551800-16567800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr9:16552000-16567800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:16552800-16566600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr9:16552800-16570200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr9:16552800-16571000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr9:16552800-16571400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr9:16553000-16570200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr9:16553000-16575200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr9:16556400-16566000 | Weak transcription | Fetal Stomach | stomach |
13 | chr9:16556400-16569200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr9:16556400-16570600 | Weak transcription | NHLF | lung |
15 | chr9:16556400-16575600 | Weak transcription | HSMM | muscle |
16 | chr9:16560200-16571200 | Weak transcription | Ovary | ovary |
17 | chr9:16560200-16571400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
18 | chr9:16560200-16571600 | Weak transcription | Stomach Smooth Muscle | stomach |
19 | chr9:16563400-16564600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr9:16563600-16564200 | Enhancers | Osteobl | bone |
21 | chr9:16564200-16570600 | Weak transcription | Osteobl | bone |
22 | chr9:16564400-16564600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
23 | chr9:16564600-16566600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
24 | chr9:16564600-16570600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |